Advertisement

Chapter 16. Special Considerations Relative to Pediatric Obesity

Michael Rosenbaum, M.D.
Associate Prof of Pediatrics and Medicine, Associate Director, CRC, Columbia Medical School, New York, NY, USA

Updated: October 20, 2007

Downloads


Introduction

Obesity, hyperlipidemia, hypertension, and other risk factors for cardiovascular disease in children track well into adulthood [1-12]. In 40 to 50 year follow-up studies of obese and lean adolescents (defined on the basis of body weight-for-height indices), adolescent fatness was a powerful predictor of mortality, cardiovascular disease, colorectal cancer, gout, and arthritis irrespective of body fatness at the time that the morbidity was diagnosed [13]. It may be said, therefore, that the metabolic groundwork for the degenerative disease of adulthood is laid down in childhood. Even more so than in adults, the overweight pediatric patient must be assessed for both current adiposity-related morbidities and the risk that such morbidities will develop in the future. The clinician should seek to identify the child "at-risk" for adiposity-related morbidity (primarily identifying genetic risk), as well as the already-obese child, with the goal of encouraging a lifestyle (primarily reduce environmental risk) and, in some cases recommending more aggressive therapeutic intervention, which will minimize obesity and it's co-morbidities.

Definition and Epidemiology

Pediatric obesity may be defined functionally as a maladaptive increase in the mass of somatic fat stores. The ideal diagnostic criteria of obesity would include some assessment of current adiposity-related morbidity and the risk of persistence of the obesity into adulthood as well as the risk of future morbidities that would be worsened by excess weight. The degree or risk for such morbidities and for the persistence of obesity into adulthood must be incorporated into decisions as to what therapeutic intervention is indicated. There are a number of basic principles that are pertinent to such an assessment.

  1. The risk of persistence of pediatric obesity into adulthood increases with age, independent of the length of time that the child has been obese [10].

  2. The risk of adiposity-related morbidity is strongly influenced by family history of such morbidities, regardless of whether affected family members are obese [10, 14, 15].

  3. Growth patterns are familial. A mildly overweight teenager with a family history of excessive weight gain in adulthood may be at greater risk for subsequent obesity than a more severely overweight teenager with a negative family history of obesity in adulthood [14].

Body mass index (BMI, weight (kg)/{height (m)}2) is a surrogate measure of body fatness which correlates quite well with direct measures of body fatness within a population [16, 17]. Adults are subclassified as overweight or “at-risk” for adiposity-related morbidities if BMI is between 25 and 30 kg/m2 and as obese is BMI > 25 kg/m2 [18]. These definitions cannot be used in children because normative values for BMI are highly age-dependent [19] (see Table 1). Because normative values for BMI are highly age-dependent and BMI values in children are significantly lower than in adults at the same level of adiposity [19], a classification system based on percentiles for BMI in children has been suggested. Children with BMI in the 85%ile – 95%ile of BMI for age and gender are defined as “at-risk” for overweight while those with BMI>95%ile are defined as overweight [20]. Growth charts of age/sex specific BMI percentiles are now available and can be downloaded directly from the Centers for Disease Control ( http://www.cdc.gov/nchs/data/ad/ad314.pdf).

Table 1. Mean BMI (kg/m 2) of Children Enrolled in NHES II or III (1963-70) or NHANES III (1988-94) [19]

Age (years)

6

7

8

9

10

11

12

13

14

15

16

17

Males

NHES II or III

15.6

15.9

16.3

16.9

17.1

17.9

18.4

19.4

20.2

20.9

21.3

22.1

NHANES III

16.3

16.5

17.3

18.0

18.4

19.4

20.1

20.5

22.3

22.3

22.3

23.4

Females

NHES II or III

15.4

15.8

16.4

17.0

17.6

18.2

19.2

19.9

20.8

21.4

21.9

21.7

NHANES III

16.1

16.9

17.3

18.2

18.4

19.4

20.2

21.8

22.4

21.9

23.0

23.3

BMI provides no direct measure of body fat and individuals at the extremes of body composition (either extremely high or extremely low percentages of body fat) may be incorrectly labeled as non-overweight or as overweight, respectively, solely based on BMI. In such cases, if the clinician is uncertain whether a child with an elevated BMI has an elevated body weight predominantly due to an abnormally large adipose tissue or lean body mass or suspects that a child with a normal or low BMI has an inordinately high percentage of body fat, then further evaluation of body fat by triceps skinfold thicknesses (see Table 2) may be indicated.

Table 2. 85%ile/95%ile BMI (kg/m 2) and Triceps Skinfold Thickness (mm) (Midpoint Between the Acromion and Olecranon on the Posterior Surface of the Arm) of Children Enrolled in NHANES I (1971-74) [20]

Age (years)

6

7

8

9

10

11

12

13

14

15

16

17

Body Mass Index (kg/m2)

Males

85%ile

16.5

17.3

18.1

18.9

19.7

22.3

21.3

22.1

23.0

23.8

24.6

25.4

95%ile

17.8

19.0

20.2

21.5

20.5

23.9

25.0

26.1

27.0

27.9

28.7

29.5

Females

85%ile

16.1

17.2

18.2

19.2

20.2

21.2

22.3

23.3

23.9

24.3

24.7

25.1

95%ile

17.5

18.9

20.4

21.8

23.0

24.6

26.0

27.1

28.0

28.5

29.1

29.7

Triceps Skinfold Thickness (mm)

Males

85%ile

11.1

12.4

13.7

14.9

16.0

16.9

17.3

17.1

16.4

15.8

16.0

16.6

95%ile

14.1

15.6

17.2

18.8

20.7

22.2

23.3

23.7

23.5

22.3

21.5

21.5

Females

85%ile

13.4

14.9

16.4

17.9

19.0

20.1

21.3

22.3

23.3

24.3

25.1

25.8

95%ile

15.6

17.9

20.2

22.5

24.4

26.2

28.0

29.5

30.9

32.2

33.2

34.8

As indicated in Tables 1 - 3, the overall fatness of the United States pediatric (and adult) populations and the prevalence of obesity are increasing. A 6 year old female with a BMI of 16.1 kg/m2 would have been at the 85%ile for BMI in NHES I (1971-74), but would now be the average BMI for a child in NHANES III (1988-94). The increasing fatness of the pediatric population is especially evident at the extremes of body fatness. In a study of U.S. adolescents conducted between 1988 and 1991, the prevalence of obesity (defined as BMI > 85%ile based on data obtained in the NHES survey, 1963-70) rose from 15 to 22.5% in 6-11 year olds and 15% to 21.5% in 12 –17 year olds [21]. Using the criteria of BMI described above (defining obesity in children as BMI > 95%ile based on NHES survey, see table 2), the prevalence of obesity among children aged 6-11 years has risen from 5% to 10.8%, and from 5 to 10.5% in 12-17 year olds.n [21-23]. Thus, while the prevalence of overweight increased by an average of about 40% over this time period, the prevalence of obesity has more than doubled. Such skewing of weight increases is consistent with impact of relevant environmental changes on a genetically susceptible subgroup within the population.

Table 3. Prevalence of overweight and obesity among different children in different ethnic groups in NHANES III [21] based on 85%ile and 95%ile in NHES II and III

Overweight (BMI 85-95%ile)

Obese (BMI > 95%ile)

Age 6-11 years

Age 12-17 years

Age 6-11 years

Age 12-17 years

Males

Females

Males

Females

Males

Females

Males

Females

All

21.6±2.4

22.7±2.4

22.0±2.2

21.4±2.7

11.3±1.8

12.8±1.9

10.6±1.3

8.8±1.4

Caucasian

20.5±2.8

21.5±3.7

23.1±3.1

20.3±3.5

10.4±2.4

14.4±2.7

9.8±2.0

8.3±1.6

African-American

26.5±2.7

31.4±4.0

21.1±3.7

29.9±4.5

13.4±2.3

9.3±2.4

16.9±2.8

14.4±3.1

Hispanic-American

33.3±3.0

29.0±2.1

26.7±4.6

23.4±3.0

17.7±2.3

12.8±3.2

14.3±1.7

8.7±2.5

The interaction of genetic factors favoring storage of calories as fat and an environment which is permissive to the clinical expression of this genetic tendency is thus evident in the increasing prevalence of pediatric (and adult) obesity. Although there are clearly genetic influences on susceptibility to obesity (see below), the current demographics of obesity, and the large increases in the prevalence of obesity over a single decade must reflect major changes in environmental factors. Such secular trends may also be taken as tacit evidence that some instances/aspects of obesity are responsive to, and therefore, preventable by, environmental manipulation (e.g., diet, physical activity, improved pre-natal and peri-natal care). However, the resistance of obesity to current therapies (including a variety of environmental and behavioral manipulations) is reflected in an overall 75-95% reported recidivism rate to obesity among formerly-obese adults and children [24-29]. Environmental and ethnographic risk-factors for obesity are summarized in Table 4 below.

Table 4. Environmental and ethnographic risk factors for obesity in children [21, 22, 30-36]

Socioeconomic Risk Factors for Obesity

Ethnographic Risk Factors for Obesity

  • Urban versus Rural Dwelling

  • Smaller (<5) versus Larger Families

  • Single Parent or Older Parent Families

  • Less Educated Parents

  • Living in the Northeast > Midwest > South > West

  • Lower Socioeconomic Status

  • African Americans

  • Hispanic-Americans (Latinos)

  • Asian-Americans

  • Native-Americans

Medical Morbidities Associated with Obesity in Children

As in adulthood, obesity in childhood adversely affects every organ system. As discussed above, adiposity-related morbidities, such as hyperlipidemia, track well into adulthood [9] (see Table 5) and pediatric obesity may be considered as an independent risk factor for adult adiposity-related morbidities, even if the obesity does not persist [13]. Certain morbidities, such as slipped capital femoral epiphyses, are the consequence of the biomechanical stresses associated with excess weight while others, especially cardiovascular morbidities, appear to be more closely related to the relative centraltiy of body fat distribution rather than absolute fat mass. Also, adiposity-related morbidities, such as hyperlipidemia, which are evident in childhood track well into adulthood. The psychological stress of social stigmatization imposed on obese children may be just as damaging to some children as the medical morbidities. These negative images of the obese are so strong that growth failure and pubertal delay have been reported in children due to self-imposed caloric restriction arising from fears of becoming obese [37].

Table 5. Pediatric Adiposity-Related Morbidities [38, 39]

Cardiovascular

Most common identifiable cause of pediatric hypertension, ­ total cholesterol, ­ low density lipoproteins,  high density lipoproteins, syndrome X

Respiratory

Abnormal respiratory muscle function and central respiratory regulation, difficulty with ventilation during surgery, lower arterial oxygenation, sleep apnea, Pickwickian Syndrome , more frequent and severe upper respiratory infections

Orthopedic

Coxa vara, slipped capital femoral epiphyses, Blount's disease, Legg-Calve-Perthe's disease , degenerative arthritis

Dermatologic

Intertrigo, furunculosis, acanthosis nigricans (HAIR-AN Syndrome)

Immunologic

Impaired cell-mediated immunity, polymorphonuclear leukocyte killing capacity, lymphocyte generation of migration inhibiting factor, and maturation rates of monocytes into macrophages

Endocrine Changes Associated with Obesity in Children

While certain endocrinopathies, such as hypothyroidism, may precipitate weight gain, the vast majority of endocrine disorders associated with obesity are secondary to excess body fat and will correct with weight loss (see Table 6). There are, however, a number of endocrine or genetic syndromes in which obesity is part of a distinct symptom complex that often includes poor statural growth (e.g., hypercortisolism, hypothyroidism) (see Table 7) and/or very distinct heritable phenotypes (e.g., Prader-Labhart-Willi; Bardet-Biedl) (see Table 8) that are discussed in more detail in other chapters of this textbook(see Chapter 8, OBESITY SECTION). Assessment of skeletal maturation by bone age, and physical examination for the presence or absence of age-appropriate secondary sexual characteristics as well as syndrome-specific morphology or symptomatology (e.g., hypotension, constipation in hypothyroidism, centripetal distribution of fat in hypercortisolism) can usually rule out these syndromes as causes of obesity.

Table 6. Endocrine Changes Associated with Obesity in Children [38, 39]

Somatotroph

 basal and stimulated growth hormone release , normal concentration of insulin-like growth factor-I, accelerated linear growth and bone age

Lactotroph

­ basal serum prolactin but  prolactin release in response to provocative stimuli

Gonadotroph

Early entrance into puberty with normal circulating gonadotropin concentrations may be due to earlier priming of the hypothalamic-pituitary-gonadal axis by estrogens created by aromatization of androgens in adipose tissue and/or by increased circulating concentrations of leptin associated with higher adipose tissue mass.

Thyroid

Normal serum T­4 and [reverse T3, normal or ­serum T3,  TSH-stimulated T4 release

Adrenal

Normal serum cortisol but ­ cortisol production and excretion, early adrenarche, ­ adrenal androgens and DHEA, normal serum catecholamines and 24 hour urinary catecholamine excretion

Gonad

 circulating gonadal androgens due to  sex-hormone binding globulin, dysmenorrhea, dysfunctional uterine bleeding, polycystic ovarian syndrome

Pancreas

­ fasting plasma [nsulin, ­ insulin and glucagon release, ­ resistance to insulin-mediated glucose transport

Table 7. Other Diseases and Injuries Associated With Obesity [40]

Disease

Structural/Biochemical Lesion

Clinical Features

Acquired hypothalamic lesions

Infectious (sarcoid, tuberculosis, arachnoiditis, encephalitis), vascular malformations, neoplasms, trauma

Adipocyte hypotrophy with little hyperplasia, headache and visual disturbance, hyperphagia, hypodipsia, hypersomnolence, convulsions, central hypogonadism-hypothyroidism-hypoadrenalism, diabetes insipidus, hyperprolactinemia, hyperinsulinism, type IV hyperlipidemia

Cushings

Hypercortisolism

Moon facies, central obesity,  lean body mass, glucose intolerance, short stature

Growth Hormone Deficiency

Impaired production of GH (pituitary)or GHRH (hypothalamus)

Short stature, obesity, increased risk of elevated cholesterol. Fat distib. Choles effect probably much greater in hypot.

Hypothyroidism

Hypothalamic, pituitary, or thyroidal

Hypometabolic state (constipation, anemia, hypotension, bradycardia, cold intolerance), cretinism (if congenital)

Obesity and Type 2 Diabetes in Children

Like pediatric obesity, the prevalence of type 2 diabetes in childhood is increasing in epidemic proportions. Until recently, type 2 diabetes mellitus (type 2 DM) was considered an ‘adult’ disease and, as of 10 years ago, constituted less than 2% of the new cases of DM in children. Currently, the burden of diabetes, and of obesity the prevalence of which is increasing at a rate of 20-30% per decade, falls disproportionately on African- and Hispanic- Americans, in whom between 25% and 50 % of new-onset childhood diabetics are type 2 [19, 21, 30, 41-43]. Thus, along with the increasing prevalence of obesity among children, type 2 DM has become a “pediatric” disease, producing the same renal, ophthalmological, neurological and cardiovascular morbidities in children with type 2 DM as in type 2 diabetic adults [44]. This is more worrisome because there is increasing evidence that morbidities accrue faster in pediatric-onset compare to adult-onset type 2 diabetes [45].

Obesity is the major risk factor for type 2 DM in adolescents [46, 47] and adiposity accounts for approximately 55% of the variance in insulin sensitivity in children [48]. As in adults, 50-90% of children with type 2 DM, and especially those of African-American or Latino descent, have a BMI>85%ile [19,21,30,42,43,46,47]. After controlling for adiposity and body fat distribtuion, insulin sensitivity has been reported to be approximately 40% higher in African-American than Caucasian pre-pubertal children but about 35% lower in adolescents [49-52], suggesting that the African-American teenager tends to become insulin resistant at a lower level of body fatness.

The pathophysiology of type 2 DM is discussed elsewhere in this textbook 9SEE CHAPTERS 9 AND 27, Diabetes Section). Type 2 DM is a complex metabolic disorder reflecting, in most instances, interactions among genes that influence an individual’s susceptibility to diabetes and an environment which favors the expression of that susceptibility by providing easy access to calorically dense foods and opportunities for a sedentary lifestyle [53]. In studies of adults with a strong family history of type 2 DM, it appears that impaired pancreatic islet-cell function is the first identifiable metabolic abnormality in some subjects who subsequently develop type 2 DM, while in other populations, insulin resistance is the first identifiable phenotype [54, 55], These data, along with the observation that subjects may be insulin-resistant but not diabetic, and that many of the individuals with impaired β-cell function may not go on to develop type 2 DM [56, 57], suggest that type 2 DM is due to a combination of insulin-resistance and impaired β-cell ability to respond to that state of insulin-resistance. In this sense, a state of relative insulin resistance, or the expression of an underlying tendency towards conditions associated with insulin resistance the major causes of which in adolescence would be pubertal hormonal changes and/or obesity, may act to “unmask” a pre-diabetic state of impaired insulin secretion in some individuals. Available evidence suggests that the incidence of type 2 DM in children peaks around puberty, as do the ethnic differences in the prevalence of pediatric obesity [21, 43]. This is not unexpected in view of the known decline in insulin-sensitivity and increase in adiposity in the peripubertal period [47,58,59] and is fully consistent with a model of type 2 DM in children in which increased insulin-resistance unmasks and exacerbates an underlying, perhaps longstanding, impairment of insulin secretory capacity.

Body fat distribution, usually defined on the basis of waist circumference or the ratio of waist-to-hip circumference, is an independent predictor of adiposity-related insulin insensitivity in adolescents and adults [47 Frerichs, 1979 #546,60]. There appear to be effects of ethnicity on the relative impact of body fat distribution on insulin sensitivity. In Caucasian-American children visceral adiposity is the best correlate of hyperinsulinism and insulin secretion during OGTT and of glucose disposal during glucose clamp studies [47]. In African American, but not Caucasian, pre-pubertal children, intraabdominal adipose tissue volume measured by magnetic resonance imaging was significantly correlated with fasting insulin concentrations and with insulin sensitivity as measured by area under the curve (AUC) during oral glucose tolerance testing [50, 51, 61]. Other studies of prepubertal children have found that fasting insulin concentrations and insulin sensitivity are significantly correlated with subcutaneous, but not visceral, adipose tissue volume in African-American prepubertal girls [62]. Because of the increasing frequency of type 2 DM among obese adolescents, and the worsening of diabetes-related morbidities that may result from delayed diagnosis, the clinician should be alert to the possible of type 2 DM in all obese adolescents, and especially those with a family history of early-onset (< 40 years of age) type 2 diabetes [63].

Molecular Genetics of Body Fatness

Heritability of Body Fatness

The storage of excess calories as fat would have been highly advantageous to our progenitors and would have conferred a reproductive advantage by increasing survival during periods of prolonged caloric restriction, as well as increasing the fertility of women and enhancing their ability to breastfeed their offspring. The opportunities for our distant forebears to consume calories to the point of morbid obesity and the frequency of their survival to an age at which such morbidities (type 2 diabetes, hypertension, hyperlipidemia) would be evident were both very low. Thus, it is likely through natural selection that the human genome would be enriched with genes favoring the storage of calories as adipose tissue [64, 65] Conversely, there would be very few, if any, evolutionary pressures to discourage obesity and ‘defend’ body thinness.

With the possible exceptions of the rare cases of obesity due to single gene mutations (see below) or specific anatomic/endocrine lesions (see above), body fatness is a continuous quantitative trait reflecting the interaction of development and environment with genotype. Twin and adoption studies indicate that the heritability of body fatness and of body fat distribution in adulthood is 65 to 80%, (approximately equal to the heritiability of height and greater than the heritability of schizophrenia (68%) or breast cancer (45%)) [66]. Recent studies have also identified significant genetic influences (heritability greater than 30%) on resting metabolic rate, feeding behavior, food preferences, and on changes in energy expenditure which occur in response to overfeeding [40,67-74]. Genetic influences on resting energy expenditure (REE) are evidenced by studies demonstrating that African-American children tend to have lower REE than Caucasian-American children, even when adjusted for body composition, gender, age, and pubertal status [75].

The calculation of heritability in twin studies is based on the assumption that each member of a monozygotic or dizygotic pair is reared in the same environment, and that the degree to which body fatness is more similar within mono- than dizygotic twin pairs is due to the greater genetic similarity of identical vs. non-identical twins. Studies comparing adopted children with their adoptive and their biological parents assume that each child shares little or none of the immediate environment with each biological parent, and that the degree to which body fatness is more similar between children and their biologic vs. adoptive parents is due to the 50% of their genotype that each child shares with each biological parent.

Single Gene Mutations Producing Obesity

There are rare instances of single gene/locus disorders which result in human obesity (e.g. Prader-Willi, Bardet-Biedl, Ahlstrom, Cohen), in association with other often dysmorphic phenotypes [40, 76] (see Table 8). The pivotal role of genetics in the control of body weight is confirmed by the existence of single gene mutations capable of producing profound increases in body fat content. The fact that mutations in different genes can produce obesity suggests that these genes may be part of a control system for the regulation of body weight, i.e., that feeding behavior and energy expenditure are integrated in a system with complex control mechanisms which can be disrupted at many loci. As shown in Table 9, there are human orthologs of known rodent obesity mutations that affect specific aspects of the energy homeostastic signaling system described in chapter 6, Obesity Section.

Table 8. Human Single Gene Mutations Associated with Obesity [40]

Syndrome

Chromosome

Phenotype

Prader-Labhart-Willi

15q11-q12

(Uniparental Maternal Disomy)

Short stature , small hands and feet, mental retardation, neonatal hypotonia, failure to thrive, cryptorchidism, almond-shaped eyes and fish-mouth

Alström

2p14-p13

(Recessive)

Childhood blindness due to retinal degeneration, nerve deafness, acanthosis nigricans, chronic nephrophathy, primary hypogonadism in males only, type II diabetes mellitus, infantile obesity which may diminish in adulthood.

Bardet-Biedl

16q21

15q22-q23

Retinitis pigmentosa, mental retardation, polydactyly, hypothalamic hypogonadism, rarely glucose intolerance, deafness, or renal disease

Carpenter

Unknown

(Recessive)

Mental retardation, acrocephaly, poly- or syndactyly , hypogonadism (males only)

Cohen

8q22-q23

(Recessive)

Mental retardation, microcephaly, short stature, dysmorphic facies

Prohormone Convertase

5q15-q21

(Recessive)

Abnormal glucose homeostasis, hypogonadotropic hypogonadism,

hypocortisolism, and elevated plasma proinsulin and POMC

Beckwith-Wiedemann

11p15.5

(Recessive)

Hyperinsulinemia, hypoglycemia, neonatal hemihypertrophy (Beckwith-Wiedemann Syndrome), intolerance of fasting

Neisidioblastosis

11p15.1

(Recessive or Dominant)

Hyperinsulinemia, hypoglycemia, intolerance of fasting

Pseudohypo-parathyroidism (type IA)

20q13.2

(Recessive)

Mental retardation, short stature, short metacarpals and metatarsals, short thick neck, round facies, subcutaneous calcifications, increased frequency of other endocrinopathies (hypothyroidism, hypogonadism)

Leptin

7q31.3

(Recessive)

Hypometabolic rate, hyperphagia, pubertal delay, infertility, impaired glucose tolerance due to leptin deficiency.

Leptin Receptor

1p31-p32

(Recessive)

Hypometabolic rate, hyperphagia, pubertal delay due to deranged leptin signal transduction.

POMC

2p23.3

(Recessive)

Red hair, hyperphagia, adrenal insufficiency due to impaired POMC production.

MC4 receptor

18q22

(Dominant)

Obesity early onset hyperphagia, increased bone density

Similarly, a number of single gene mutations associated with obesity have been identified in rodents. Human orthologs are known for all rodent genes that are associated with obesity and, in the case of Lep and Lepr, human mutations associated with obesity have been reported (see Table 9).

Table 9. Rodent Single Gene Mutations Associated with Obesity [40, 77]

Gene Name (rodent)

Symbol

Mutation (Name)

Chromosome

Phenotype

Human Chromosome

Agouti (mouse)

A

A y(yellow)

2

Adult-onset obesity, yellow coat color, hyperphagia, due to ectopic overexpression of agouti signaling protein (ASP) leading to MC4 receptor blockade.

20q11.2

Carboxypeptidase E

(mouse); Cpe

Cpe fat(fat)

8

Adult obesity, possibly due to impaired processing of prohormones.

4q32

Leptin (mouse)

Lep

Lep ob(obese)

6

Early-onset obesity, hyperphagia, hypometabolic rate, infertility, diabetes, increased partitioning of stored calories as fat due to leptin deficiency.

7q31.3

Leptin Receptor

(mouse/rat); Lepr

Lepr db(diabetes)

Lepr fa(fatty rat)

Early-onset obesity, hyperphagia, hypometabolic rate, infertility, diabetes, increased partitioning of stored calories as fat due to deranged leptin signal transduction.

1p31-p22

Tubby (mouse)

tub

Tub (tubby)

7

Impaired G-protein coupled receptor (possibly serotonin) signaling in the hypothalamus. This gene is a transcription factor. Get that across. Problem is not with g protein per se.

11p15

OLETF (rat)

Cckar

Cckar OLETF

Adult obesity and hyperphagia due to CCK receptor deficiency

4p16.2-p15.1

Factors in the Pediatric Environment Affecting the Risk of Obesity and Adiposity-Related Morbidities

Pre-Natal Undernutrtion

Studies that examine the prevalence of obesity in children conceived during periods of natural or man-made famine such as the Nazi-imposed Dutch famine of 1944-45 (the “Winter Hunger”) [78] report a small but statistically significant increase in the prevalence of obesity (defined as weight for height greater than 120% of WHO standards for 1948) in 19 year old male military recruits whose mothers were malnourished only during the first trimester of pregnancy (2.77% prevalence if mother was in famine area vs. 1.45% if mother was outside of famine area during pregnancy) and a decrease in in the prevalence of obesity among recruits whose mothers were malnourished during the child’s immediate post-natal period (0.82 % if mother was in famine area vs. 1.32% if mother was outside of famine area during pregnancy). It has been hypothesized that early intrauterine malnutrition might affect hypothalamic ("appetite center") development while the anti-obesity effects of early post-natal malnutrition might be due to suppression of adipocyte formation.

Long-term tracking studies of children who are small for gestational age, and therefore demonstrating clinical evidence of prenatal undernutrition, have reported that, even when corrected for adult adiposity, birthweight is negatively correlated with the incidence of adiposity-related morbidities, including type 2 diabetes mellitus, hypertension, stroke, and cardiovascular disease, in adulthood, even when corrected for adult adiposity [79-84]. This association implies an interaction between the prenatal environment and development/function of pancreatic beta-cells or other organs, e.g., hypothalmus, liver, etc.,. that are involved in the regulation of adult energy homeostasis and cardiovascular function. As hypothesized by Barker [85-87] the metabolic, cardiovascular, and endocrine bases for adult adiposity-related morbidities may originate through adaptations that the fetus makes in response to undernourishment. Therefore, the small-for-gestational-age baby should be considered to be at increased risk for adult moribidities that are exacerbated by increased adiposity [64].

A “thrifty genotype” hypothesis and a “catch-up growth” hypothesis have been proposed as mechanistic explanations for the association between low birth weight and adiposity-related co-morbidities. In the 'thrifty genotype' view, intrauterine undernutrition invokes insulin resistance and islet cell dysfunction that favor delivery of nutrients to vital organs over somatic growth [88]. Postnatally, in the nutrient-rich extrauterine environment, this tendency to optimize the efficiency of storing calories in the setting of insulin resistance would favor the development of obesity, diabetes, and dyslipidemia. In the 'catch-up growth' view intrauterine undernutriton provokes decreased insulin and insulin-like growth factor production [89]. When the production of these molecules increases during the calorically-rich post-natal catch up growth phase, tissues respond by becoming insulin and insulin-like growth factor resistant to protect against hypoglycemia [90]. In either view, resistance to the auxotrophic actions of insulin and other growth-promoting factors (e.g., insulin-like growth factors) act to maximize energy storage at the expense of growth in the setting of an unstable food supply and in which genes that reduce insulin secretion or increase insulin resistance also predispose infants to low birthweights. Once adequate nutrients are available, these phenotypes that minimized energy expenditure in growth now predispose to obesity and type 2 diabetes [91, 92]. In addition, it is certainly possible – even likely – that intrauterine dysnutrition also influences brain development in a manner that could also predispose to neuroendocrine and behavioral phenotypes favoring increased adiposity and its co-morbidities. More recently, maternal smoking in the first trimester of pregnancy has been associated with increased body fatness and blood pressure in childhood [93], perhaps via effects on blood flow to the developing fetus.

Prenatal Overnutrition

The infant of the diabetic mother (IDM) is a model for the influences of fetal overnutrition on post-natal adiposity . The high ambient glucose concentrations of the prenatal environmnt stimulates fetal hyperinsulinemia, increased lipogenesis, and macrosomia. Since gestational diabetic women are often obese, it is difficult to separate the metabolic effects of gestational diabetes on subsequent adiposity of the IDM from the possibility that the mother has transmitted a genetic tendency towards obesity to her offspring. In studies controlled for the effects of maternal adiposity, being an IDM is still associated with an increased risk of obesity, independent of the degree of maternal obesity [94-97].

Early Feeding Practices

Accurate assessment of the effects of early infant feeding practices on subsequent adiposity must control for possible effects of maternal adiposity as well as socioeconomic status and other factors that may affect the ability to breastfeed [98]. A number of recent well-designed studies have suggested that predominantly breastfeeding for at least 6 months is associated with an approximately 20-30% reduction in the prevalence of obesity (defined as BMI > 95%ile for age and sex) through early adolescence [99, 100] but not into adulthood [101], even when controlled for other adiposity-risk variables. Neither the age at which specific foods are introduced into the diet nor the proportions of fat, carbohydrate or protein in the diet significantly influence subsequent adult adiposity[102, 103]. However, the institution of a well-balanced diet in childhood may form the basis for long-term healthy dietary habits that will significantly lower cardiovascular disease risk even if the diet composition does not substantially affect body composition.

Physical Activity

Significant negative correlations have been reported between physical activity and body fatness in pre-school children while positive correlations have been noted between adiposity and the amount of time spent watching television in adolescence [104-108]. Over 60% of television commericals during children’s programs are food-related, and television watching promotes both inactivity and increased caloric intake [109].

Energy Homeostasis

The first law of thermodynamics dictates that the accumulation of stored energy (fat) must be due to caloric intake in excess of energy expenditure. A sustained small excess of energy intake relative to expenditure will, over time, lead to a substantial increase in body weight. For example, an individual increasing daily caloric intake by 150 kcal (8 ounces of whole milk) above usual daily energy expenditure, would gain approximately 8 pounds before a new equilibrium between energy intake and expenditure (due to increased body mass) was reached. Despite the potentially large effects of small imbalances in energy intake versus expenditure, adults maintain a relatively constant body weight and most children tend to grow steadily along their respective weight percentile isobars for age, with little conscious effort to regulate energy intake or expenditure. The high rate of recidivism to previous levels of fatness of reduced-obese children and adults[24-29], and the tendency for individuals to maintain a relatively stable body weight over long periods of time despite variations in caloric intake [110], provide empirical evidence that body weight is regulated. Energy intake and expenditure are responsive to complex interlocking control mechanisms in which numerous afferent signals from the gastrointerestinal, endocrine, central and peripheral nervous system, and adipose organs are ‘sensed’ by central nervous system tracts whose efferents affect energy intake and expenditure [14, 111].

The relative long-term constancy of body weight in humans, their lack of success in sustaining therapeutic weight loss, and the hypometabolism and hyperphagia that accompany weight decrease provide strong evidence that weight (fat) is biologically regulated. The amount of energy stored in the body as fat exerts potent effects on growth, pubescence, fertility, autonomic nervous system activity, and thyroid function, suggesting that humoral “signals” reflecting adipose tissue mass interact directly or indirectly with many neuroendocrine systems [111-116]. Weight loss and maintenance of a reduced body weight are accompanied by changes in autonomic nervous system function (increased parasympathetic and decreased sympathetic nervous system tone), circulating concentrations of thyroid hormones (decreased triiodothyronine and thyroxine without a compensatory increase in TSH), and circulating concentrations of glucocorticoids (increased cortisol) [112, 117, 118] that are consistent with a homeostatic resistance to altered body weight, acting, in part, through effectors that mediate energy expenditure. Such a neurohumoral system to protect body energy stores would convey clear evolutionary advantages. During periods of undernutrition, the perceived reduction in energy stores would result in hyperphagia, hypometabolism, and decreased fertility (protecting females from the increased metabolic demands of pregnancy and lactation and the delivery of progeny into inhospitable environments). While carefully controlled studies of the effects of weight loss on energy expenditure in children are not yet available, the high rate of recidivism to previous levels of fatness among reduced obese children suggests that these same systems are operant [14,15, 119-121].

Identification of the Child Who is “At-risk” for Adiposity-related Morbidity

The rapid increase in prevalence of obesity in the United States pediatric population during the last 25 years demonstrates the potent effects of environment on adiposity. Obesity’s intractable nature is reflected in the recidivism rate to obesity among formerly-obese. Until recently, the recidivism rate was felt to be as high as 90-95%[24, 25]. More recent studies by Hill et al analyzing data from the National Weight Control Registry [26] have reported recidivism rates of 75%, implying that obesity may be more treatable via lifestyle modification, such as increased physical activity and decreased caloric intake [27-29], than previously supposed. The high heritability of body fatness, coupled with the increasing prevalence of obesity, suggests that it is rank order of body fatness within a given environment that is genetically determined, rather than the absolute level of body fatness. Thus, a child or adult who is at the 85%ile for body fatness among a population of sedentary individuals may, bir virtue of altering their lifestyle, decrease their absolute level of body fatness such that they are at the 85%ile among a population of physically active, diet-conscious individuals.

Obesity is only one of many possible risk factors for type 2 diabetes mellitus and cardiovascular disease. Other risk factors include, low birthweight, family history of such morbidities, or of other morbidities, such as osteoarthritis, which are worsened by excess body weight. Healthful dietary and exercise habits that are introduced early in life are more likely to persist into adulthood..The pediatrician can, by beginning early intervention to encourage a healthy lifestyle in the form of a heart healthy diet and regular exercise, encourage lifestyle changes that will minimize the likelihood of adiposity-related morbiditiy, regardless of whether or not absolute body fatness is reduced.

The physician should seek to identify the child "at-risk" for adiposity-related morbidity, as well as the already-obese child, with the goal of encouraging a lifestyle (environment) which will minimize obesity and it's co-morbidities. A detailed history and physical examination should be performed to assess each child for current obesity-related morbidities and for family history that suggests risk of such morbidities. Anthropometric data should be plotted on height and weight velocity charts, as well as standard curves of body mass index), with the aim of detecting increased weight gain velocity before actual obesity occurs. Any child, regardless of body weight, with a history in first-degree relatives of obesity, type 2 diabetes mellitus, hypertension, hyperlipidemia or premature myocardial infarction and any child with body mass index above the 85%ile (see Table 2) should be considered to be "at risk" for adiposity-related morbidity.

As stated above, obesity is only one of many possible risk factors for cardiovascular disease. Since the adverse cardiovascular effects (such as hyperlipidemia, diabetes, and hypertension) are often cumulative, a combination of a cholesterol-lowering diet and program of regular exercise may be sufficient to reduce cardiovascular morbidity even if body weight is not significantly altered [122-126]. Children with a strong family history of any morbidity which can be exacerbated by obesity should be firmly and repeatedly counseled regarding good dietary and exercise habits, regardless of whether or not there is a family history of obesity per se.

Initial Evaluation and Decision Whether or Not to Initiate Therapy (Figure 1)

Figure 1. EVALUATION OF THE OVERWEIGHT CHILD (based on American Academy of Pediatrics Expert Committee Recommendations [127] and reprinted with permission from the American Academy of Pediatrics Nutrition Handbook, 5th edition, 2002, Chpater 33, Obesity.)

EVALUATION OF THE OVERWEIGHT CHILD (based on American Academy of Pediatrics Expert Committee Recommendations [127] and reprinted with permission from the American Academy of Pediatrics Nutrition Handbook, 5th edition, 2002, Chpater 33, Obesity.)

Not every obese child requires or will benefit from treatment. The likelihood of persistence of pediatric obesity into adulthood increases with age. The obese 2 year old is about twice as likely as a non-obese 2 year old to become an obese adult. In contrast, that risk increases to 6 or 7 fold by adolescence, independent of the duration of the obesity. In large epidemiological studies, if neither of a child’s parents is obese, the likelihood of childhood obesity persisting into adulthood may actually be less than the risk for a non-obese child with one or two obese parents [10].

Because risk of persistence is lower and risk of treatment-associated impairment of statural or brain growth is higher, caloric restriction to reduce weight should not be used in infants less than 2 years of age. Though hypothyroidism is an unusual cause of obesity in infants, the profound neurologic sequelae of untreated hypothyroidism in infancy justify heightened attention to this possibility. Similarly, children less than 2 years of age who are severely obese, especially if they have concurrent adiposity-related morbidities, evidence of developmental delay, or other phenotypic features associated with the rare obesity syndromes (such as Prader-Labhart-Willi) discussed above (see Table 7), should be referred to a physician who specializes in the treatment and evaluation of pediatric obesity [127].

The decision as to whether or not to initiate therapy in the toddler (ages 2-9) should be strongly influenced by family history of obesity and adiposity-related morbidities. For the pre-adolescent or adolescent child with obesity-related morbidity (e.g., hypertension), the child with central, and/or he child with a strong family history of adiposity-related morbidity (e.g., hyperlipidemia, hypertension, diabetes mellitus), medical evaluation might also include screening for hyperlipidemia (fasting cardiovascular disease risk profile) and an oral glucose tolerance test.

Before beginning any type of therapy it is essential to have the cooperation of the child and his/her family [128, 129]. Clinicians should not assume that the obese child is necessarily depressed, or that every obese child is significantly motivated to lose weight. Beginning weight-loss therapy if the overweight child and his/her family are not motivated to do so is likely to be unsuccessful and may have negative influences on the child’s self-esteem and likelihood of future successful weight loss [127] and so therapy should not be initiated in such a family environment.

The clinician should begin assessment of family therapeutic readiness by asking the entire family how concerned they are about the patient’s overweight, in a supportive manner designed to elicit cooperation from the family and patient, i.e., ask “Do you feel that weight is a problem?” or “What do you think that you could change to help you lose weight?” rather than, “Why can’t you control what you eat?” The discussion should emphasize the potential benefits of therapeutic intervention, including the importance of cooperation of all caregivers, the increased likelihood of diminishing adult body fatness if a more healthy lifestyle is adopted earlier, the fact the there are potential medical complications of obesity (some of which may already be evident in other family members), and that the entire family will benefit from adopting a healthier lifestyle. It is also important to emphasize that whatever lifestyle changes are made to diminish body fatness will take time and must be continued in the long-term if body fatness reduction is to be maintained.

Initial evaluation should include a dietary history of the child’s and family’s typical eating habits (including snacks and the frequency with which they consume foods prepared outside of the home). A physical activity history should also be obtained, including school physical education, after-school activities, activities of daily living (such as walking to school), family activities, and sedentary activities (such as television watching). Treatment of the overweight child must, of necessity, be individualized and the clinician should remain sensitive to issues such as ability of the parents to prepare meals for the patient and neighborhood safety or availability of adult supervision which may impact on the availability of physical activity after school. A complete physical examination should also be performed with special attention to the possibility of adiposity-related morbidities (hypertension, dyslipidemia, acanthosis nigricans (indicative of insulin resistance), etc., see Table 4). As discussed below, the morbidly-obese child requires more aggressive therapeutic intervention.

Therapeutic Intervention (Figure 2)

Figure 2. Therapeutic approach to obesity: Roles of physician, parents, and patient (based on American Academy of Pediatrics Expert Committee Recommendations [127] and reprinted with permission from the American Academy of Pediatrics Nutrition Handbook, 5th edition, 2002, Chapter 33. Obesity.)

Therapeutic approach to obesity: Roles of physician, parents, and patient (based on American Academy of Pediatrics Expert Committee Recommendations [127] and reprinted with permission from the American Academy of Pediatrics Nutrition Handbook, 5th edition, 2002, Chapter 33. Obesity.)

The major goal of obesity therapy should be to diminish morbidity and morbidity-risk rather than to achieve a "cosmetically endorsed" body weight. The “severity” of obesity should be assessed by degree of overweight (BMI > 95%ile for age and sex should be considered severely obese), presence of current morbidities (any overweight child {BMI > 85%ile for age and sex} who has current adiposity-related morbidity such as type 2 DM should be considered severely obese), and risk of future adiposity-related morbidity (based on family history) [127].

In the otherwise healthy overweight child with no evidence of adiposity-related morbidity, clinicians and parents are generally concerned that the child will become an obese adult. Initial therapy in such instances should be directed towards decreasing or eliminating weight growth while allowing height growth to continue at age and sex appropriate velocity so that height eventually becomes appropriate for weight. Avoidance of calorically dense foods and substitution of fruit and vegetable snacks for sugared sodas, juices, and cookies, without restricting access to such snacks, will, in most cases, result in significant slowing of weight velocity [130]. The time required to significantly reduce adiposity can be estimated. One to two years of weight maintenance (one year during normally rapid weight gain periods such as adolescence and two years during periods of slower weight gain) compensates for 20% of excess weight-for-height.

If gradual statural growth into the child’s weight is not possible because weight is already obese by adult standards (i.e., body mass is so great that BMI will still be >85%ile even if weight remains stable until adult stature is achieved), then a weight loss regimen, as outlined below, should be considered. Therapeutic weight reduction is usually indicated for the child with evidence of current adiposity-related morbidity. The hypertensive or diabetic child should endeavor to reduce weight or alter body composition within one year to the point that the morbidity is no longer evident. Needless to say, if the morbidity is more severe, e.g., Pickwickian Syndrome, then more rapid weight-reduction, even in an in-patient setting, may be necessary. The obese child with poor self-image, feelings of isolation from peers, and depression, should also attempt weight reduction, perhaps with adjunctive psychotherapy. The initial therapeutic approach for children with predominantly psychiatric obesity-related morbidities should combine exercise and a closely supervised dietary plan, preferably with the involvement of a nutritionist. Studies of compliance with weight-reduction plans have emphasized the importance of a family-oriented approach. Any therapeutic regimen should involve the entire family, as well as the child's school. Frequent physical examination of the child and monitoring of school performance should be included. Patients and their families should be made aware that the treatment period does not end once the prescribed reduction in body fatness has been achieved, and that caloric restriction must continue beyond the period of weight reduction.

Overview of Therapeutic Options

Before prescribing any type of treatment for obesity, weight reduction, health personnel should assess the risk/benefit ratio for any treatment in the particular patient. In the older and otherwise healthy overweight child without family history of adiposity-related morbidity, the fact that adolescent obesity may constitute an independent risk factor for adult mortality and morbidity must be weighed against the possible morbidities (poor statural growth, precipitation of eating disorders, etc.) associated with therapeutic weight reduction. Long-term studies of weight-reduced children and adults have shown that 75-95% return to their previous weight percentiles. Obese children and their families must recognize that maintenance of a reduced degree of body fatness will probably require a lifetime of attention to energy intake and expenditure. The cautions emphasized above in deciding who should undergo a therapeutic weight reduction, and the relatively slow rate at which weight reduction of slowing down of weight gain should be prescribed, reflect the significant morbidities associated with these processes. Diets extremely low in caloric content or with unusual distribution of calories as fat, protein, and carbohydrate may precipitate cardiac arrhythmias, severe electrolyte disturbances, or other morbidities. As many as 80% of children using unsupervised diets obtained from popular magazines have been found to suffer from weakness, headaches, fatigue, nausea, constipation, nervousness, dizziness, poor concentration, dysmenorrhea and/or fainting. Children on a supervised diet must also be closely monitored for treatment-associated psychological morbidities (stigmatization of the child, precipitation of anorexia nervosa or bulimia).

Therapeutic intervention should emphasize the need for participation of the entire family and lifelong attention to, and benefits of, a healthy lifestyle, as well as positive reinforcement for even small degrees of compliance. Preparation of the family and child for therapeutic intervention is as important as the intervention itself (see Figures 4 and 5).

Diet

Dietary restriction should never be presented in a punitive manner and, if possible, the obese child and the entire family should adhere to a similar diet to minimize feelings of isolation by the obese child. Family members, clinicians, and patients (especially adolescents) will be frustrated by the need for prolonged attention to diet and exercise that is required to achieve and maintain a reduced level of body fatness. Encouragement can be provided by examining growth and growth velocity curves with patients and their families to illustrate progress. If appropriate, the significance of any evident reduction in morbidity (e.g., lowering of blood pressure or cholesterol) can be reinforced. Reasonable goals in the form of a "target" body weight at the next visit should be set at each office visit so that the patient and parents are aware of what is expected. These goals should be modest and attainable even if patients are only moderately compliant with their diet and exercise regimens since achievement of an interval "target weight" will also encourage the patient.

The prescribed diet should initially provide 300 to 400 kcal/day below weight-maintenance requirements as assessed by dietary history or as calculated based upon formula relating anthrompometry to energy expenditure, e.g., the Harris-Benedict Equation [131]. Self-reported caloric intake is generally very inaccurate. The child's ad libitum diet should be directly observed and recorded by the parents for a minimum of 5 consecutive days. A 300-400 kcal per diem energy deficit should result in weight loss of approximately 1 pound per week.. Note that since weight reduction per se causes decreased energy expenditure (both from decreased metabolic mass and whatever hypometabolic state is invoked by losing weight [14, 40, 111] and during weight loss, periodic downard adjustments of energy intake will be necessary to sustain ongoing weight reduction. The family should be instructed in long-term monitoring of caloric intake within- and outside of- the home and cautioned not to become overly critical or punitive towards the child if weight loss is slow or compliance is suboptimal.

The composition of the diet should be in accordance with the American Heart Association “Heart Healthy” recommendations and contain at least the minimal recommend amounts of protein, essential fatty acids, vitamins, and minerals and be low in saturated fats (less than 30% of calories as fat and less than 10% of calories as saturated fat). (The American Academy of Pediatric Statement on Cholesterol in Children describes a healthful, cardiovascular-disease, risk-lowering diet [132].) Diets consisting of drastically altered proportions of nutrients may be dangerous and yield no better results than a limited intake of a nutritionally balanced diet. Nutritional counseling should encourage decreasing the use of calorically dense (high fat or fried) foods, and adding more fruits and vegetables to the daily diet. The substitution of water for non-nutritious high calorie sugar containing drinks (juices, iced teas and soda pop) may be very helpful [130]. In some cases, reductions in calorically dense foods and sugar-containing drinks through substitution and/or elimination alone, can decrease calories and weight without changing the general pattern of food consumption in the family. When families eat at restaurants and fast food places, they have less control over food choices than they do at home. Thus, reduction in the number of meals prepared outside the home may also be an effective weight-loss strategy. Parents and adult caregivers should understand the important role they play in the development of proper eating habits in their young children. The parents’ food preferences, the quantities and variety of foods in the home, the parents’ eating behavior and physical activity patterns all determine how supportive the home environment is to the obese child.

Therapeutic Exercise

Regular aerobic exercise will allow the patient to ingest more calories and hopefully encourage the long-term continuation of such a regimen. Exercise will promote increased muscle mass, thereby raising total metabolic rate, and the putative effects of exercise to reduce visceral adipose tissue mass independently lower the risk of hyperlipidemia and diabetes mellitus [133-135]. However, the energy cost of even vigorous exercise is low when compared to the caloric content of many "fast foods" or other "snacks", and exercise should not be viewed as a "license to eat". For example, walking at 3 miles per hour for 1 hour consumes about 200 kilocalories, about the same number of calories contained in a 1 ¾ ounce bag of potato chips. Obviously, "treats", such as ice cream, potato chips, etc., should not be used as incentives to exercise.

While no specific aspect of the sedentary lifestyle has been shown to directly cause obesity, behaviors such as television viewing, reading, working at a computer, driving a car or commuting do exert effects on health. Television viewing appears to be directly associated with the incidence of obesity, and inversely associated with the remission of obesity. The impact of television viewing on obesity seems to be due to both displacing more vigorous activities and its effect on diet. Not only is television viewing a sedentary behavior, but also food has constituted the most heavily advertised product on children’s television in the United States. In Mexican-American children, adiposity was significantly correlated with time spent watching television but not with time spent watching videos [136], suggesting that the bulk of the positive association of television watching and adIposity is due to the approximately 60% of advertising that is devoted to food [109]. Children and adolescents should be encouraged to view as little television as possible. Limitation of television, video games, and interrnet surfing will encourage greater participation in physical activity. Clinicians should encourage children to participate in organized or individual sports (participate, not watch from the bench) and advocate for better community- and school-based- activity programs.

If the patient is unable to lose weight and/or co-morbid conditions persist, consideration should be given to referral of the child to a physician specializing in the treatment of pediatric obesity. Weight-loss programs, weight-reduction camps, etc. are often not covered by medical insurance and should be considered for the morbidly-obese child with some caution. Enrollment in a highly supervised environment may demonstrate to an overweight child that weight loss is possible and encourage them to continue. However, rapid weight loss may precipitate cholelithiasis [137] or eating disorders. A child may become overly pre-occupied with his/her weight and, even if a moderate degree of weight-loss is achieved, lose self-esteem. Obsession with weight on the part of the child or their family may lead to serious deterioration of intra-family relationships.

Surgical and Pharmacological Intervention

Surgical or pharmacotherapy for pediatric obesity is currently not recommended. While some adolescents have been included in various reports on gastroplasty-induced weight loss, there are few studies specifically examining safety and efficacy of this procedure or other obesity surgeries in children [138, 139]. Although there is no documented role at present for surgical therapy in pediatric obesity, in some extremely obese children with life-threatening morbidity (e.g., with Pickwickian syndrome) in whom all other interventions have failed, it may be appropriate to consider such treatments. Similarly, there are currently no FDA-approved medications for use in children less than 16 years of age. However, in some extremely obese adolescent patients with life threatening morbidities, this approach may be necessary with the warning that, though clinical studies are ongoing, studies of the effectiveness of these drugs in children have not yet been reported.